Breaking News

Cytek Biosciences Expands with New Facility in Amsterdam 

Increases footprint by more than 40% with a dedicated customer service and training center.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cytek

Cytek Biosciences, Inc., a provider of spectral flow cytometry, has relocated its European headquarters to a new facility in Amsterdam’s Life Sciences District, expanding Cytek’s footprint in the EMEA region.

The new site houses Cytek European offices and warehouse, which has increased the footprint by more than 40%, with a dedicated customer service and training center. The Training Center offers a fully functional lab environment, enabling researchers to receive hands-on training with Cytek instruments. 

According to the company, this helps scientists to maximize the potential of Cytek’s Full Spectrum Profiling (FSP) technology to unlock high-dimensional data and enable laboratories to achieve more with fewer resources.

As part of a strategic initiative to advance its reagent business, Cytek has transitioned warehouse operations in-house to strengthen operational oversight and ensure the highest standards of quality and control across the supply chain. According to the company, the approach enhances organizational agility, improves operational efficiency, and accelerates turnaround times for customers.

“Europe has been a key region in Cytek’s global growth journey, and we are making investments to strengthen our presence there,” said Wenbin Jiang, Ph.D., CEO of Cytek Biosciences. “The new Amsterdam facility expands our capabilities across the EMEA region, enabling us to more efficiently deliver solutions and services that advance scientific understanding, accelerate data-driven decision-making, and foster innovation.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics